Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 13, Issue 11, Pages 3082-3096
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-07-24
DOI
10.1074/mcp.m114.038836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
- (2013) Dana Rathkopf et al. CANCER JOURNAL
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
- (2013) Min Chen et al. CLINICA CHIMICA ACTA
- Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
- (2013) Mazyar Javidroozi et al. DISEASE MARKERS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study
- (2011) Lijie Zhang et al. ACTA HISTOCHEMICA
- Tumor markers in prostate cancer I: Blood-based markers
- (2011) Shahrokh F. Shariat et al. ACTA ONCOLOGICA
- Screening for Prostate Cancer: Early Detection or Overdetection?
- (2011) Andrew J. Vickers et al. Annual Review of Medicine
- Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries
- (2011) Veerle Matheeussen et al. BIOLOGICAL CHEMISTRY
- A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas
- (2011) Terry Farrah et al. MOLECULAR & CELLULAR PROTEOMICS
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50
- (2010) Hans Lilja et al. CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Treatment of localized prostate cancer: when is active surveillance appropriate?
- (2010) Peter C. Albertsen Nature Reviews Clinical Oncology
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets
- (2009) Ingrid De Meester et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen
- (2009) Yves Fradet CURRENT OPINION IN UROLOGY
- Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry
- (2009) Josep Villanueva et al. Nature Protocols
- DPP4 inhibitors for diabetes—What next?
- (2008) Anne-Marie Lambeir et al. BIOCHEMICAL PHARMACOLOGY
- CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12
- (2008) Yan-Xi Sun et al. CLINICAL & EXPERIMENTAL METASTASIS
- Peptidase substrates via global peptide profiling
- (2008) Debarati M Tagore et al. Nature Chemical Biology
- Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era
- (2008) Fernando J. Bianco UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The role of CD26/dipeptidyl peptidase IV in cancer
- (2007) Pamela et al. Frontiers in Bioscience-Landmark
- Cysteine cathepsin proteases as pharmacological targets in cancer
- (2007) Carmela Palermo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started